Spago Nanomedical AB (publ) (SPAGO.ST)

Spago Nanomedical AB (publ) (SPAGO.ST) — VMCI valuation read

Across 120 indicators, Spago Nanomedical AB (publ) (SPAGO.ST) lands at VMCI 35/100. The Healthcare sector median is 50, so the 15-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on SPAGO.ST in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, SPAGO.ST trades at 17.0x earnings, 6% below the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of -0.1x leaves covenant headroom for SPAGO.ST on the trailing balance sheet.

SPAGO.ST rose 0.9% over the trailing 7 days, with a -13.9% read on a 30-day basis.